Skip to main content
. 2023 Jun 27;12(1):2227510. doi: 10.1080/2162402X.2023.2227510

Figure 2.

Figure 2.

Cytokine, chemokine and C reactive protein (CRP) production after i.P. administration of TL-532. After 10 treatments with either TL-532 (380 mg/kg) or vehicle (0.9% NaCl), cytokine/chemokine (a) and CRP (b) production were evaluated by ELISA 3 h after the tenth i.P. administration of TL-532 (380 mg/kg) or vehicle (0.9% NaCl). Plasmatic soluble factor secretion signature for each route of administration (i.P. i.V. or s.C.) is shown as the fold change of median values normalized to the vehicle controls (c) (n = 2–5).